Countdown to an optimized drug launch: 5 determinants of success

Understanding and addressing healthcare inequity in the United States

Shifting the care paradigm for individuals with skin of color (SOC) in the United States

Exploring the case for alternative access models

Advances in gene therapy and the impact of CAR-T cell therapy for cancer patients

EU’s new Joint Clinical Assessment (JCA): will patients have a say?